연구성과로 돌아가기
2025 연구성과별 연구자 정보 (945 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study | Sanga, Panna | Sanga, P | 18 | Janssen Res & Dev, Titusville, NJ 08560 USA | sramcha4@its.jnj.com; | |||||
| Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study | Karcher, Keith | Karcher, K | 19 | Janssen Res & Dev, Stat & Decis Sci, Titusville, NJ 08560 USA | sramcha4@its.jnj.com; | |||||
| Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study | Zhu, Yaowei | Zhu, YW | 20 | Janssen Res & Dev, Titusville, NJ 08560 USA | AAP-7961-2021 | Zhu, Yaowei | sramcha4@its.jnj.com; | |||
| Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study | Sheehan, John J. | Sheehan, JJ | 21 | Janssen Global Serv, Global Med Affairs, Raritan, NJ USA | sramcha4@its.jnj.com; | |||||
| Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised double-blind, placebo-controlled study | Sun, Hong | Sun, H | 22 | Janssen Res & Dev, Titusville, NJ 08560 USA | sramcha4@its.jnj.com; | |||||
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Jung, Hee-Yeon | Jung, HY | 1 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea | AFB-8578-2022 | Jung, Hee-Yeon | 0000-0003-0232-7202 | Jung, Hee-Yeon | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Seo, Yu Jin | Seo, YJ | 2 | Kyungpook Natl Univ, Coll Nat Sci, Dept Stat, Daegu, South Korea | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |||||
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Hwang, Deokbi | Hwang, D | 3 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Surg, Daegu, South Korea | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |||||
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Yun, Woo-Sung | Yun, WS | 4 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Surg, Daegu, South Korea | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |||||
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Kim, Hyung-Kee | Kim, HK | 5 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Surg, Daegu, South Korea | JBR-8125-2023 | Kim, Hyung-Kee | 0000-0002-4436-7424 | Kim, Hyung-Kee | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Huh, Seung | Huh, S | 6 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Surg, Daegu, South Korea | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |||||
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Yoo, Eun Sang | Yoo, ES | 7 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Urol, Daegu, South Korea | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |||||
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Lim, Jeong-Hoon | Lim, JH | 8 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea | ABE-6003-2020 | Lim, Jeong-Hoon | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |||
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Choi, Ji-Young | Choi, JY | 9 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; | |||||
| Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients | Park, Sun-Hee | Park, SH | 10 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea | jh-cho@knu.ac.kr; drcdkim@knu.ac.kr; |
페이지 이동: